Acadia Healthcare Company Inc (NASDAQ:ACHC) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 14,769,600 shares, an increase of 11.2% from the May 30th total of 13,283,100 shares. Based on an average trading volume of 733,000 shares, the short-interest ratio is presently 20.1 days. Approximately 17.2% of the company’s shares are short sold.
A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. Nordea Investment Management AB increased its position in Acadia Healthcare by 1.3% during the first quarter. Nordea Investment Management AB now owns 140,136 shares of the company’s stock worth $4,107,000 after acquiring an additional 1,758 shares during the period. Clearbridge Investments LLC bought a new stake in Acadia Healthcare in the 1st quarter valued at $12,709,000. Marshall Wace North America L.P. bought a new stake in Acadia Healthcare in the 1st quarter valued at $1,342,000. Maso Capital Partners Ltd increased its holdings in Acadia Healthcare by 5.8% in the 1st quarter. Maso Capital Partners Ltd now owns 108,200 shares of the company’s stock valued at $3,171,000 after buying an additional 5,900 shares during the period. Finally, TCW Group Inc. increased its holdings in Acadia Healthcare by 17.9% in the 1st quarter. TCW Group Inc. now owns 65,319 shares of the company’s stock valued at $1,914,000 after buying an additional 9,917 shares during the period.
ACHC stock opened at $33.34 on Tuesday. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $2.96 billion, a PE ratio of 14.88, a P/E/G ratio of 1.78 and a beta of 0.67. The stock’s 50 day moving average is $33.79. Acadia Healthcare has a 52 week low of $24.27 and a 52 week high of $45.35.
ACHC has been the topic of several analyst reports. BidaskClub cut shares of Zebra Technologies from a “buy” rating to a “hold” rating in a report on Tuesday. Mizuho set a $30.00 price target on shares of Acadia Healthcare and gave the stock a “hold” rating in a report on Friday, May 31st. BMO Capital Markets restated a “hold” rating and set a $45.00 price target on shares of SAP in a report on Wednesday, May 1st. ValuEngine cut shares of Viewray from a “buy” rating to a “hold” rating in a report on Wednesday, April 24th. Finally, TheStreet cut shares of Timkensteel from a “c-” rating to a “d+” rating in a report on Monday, June 17th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $36.80.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.